Search results
Updated Covid-19 Vaccine Targeting JN.1 Recommended By FDA Panel
Forbes· 6 days agoAccording to the panel, vaccine manufacturers should design updated vaccines to target the JN.1...
COVID-19 Virus Can Lurk in Sperm for 100+ Days After Infection
SciTechDaily· 4 days agoSARS-CoV-2 was detected in male reproductive cells under the microscope even when PCR testing failed...
Moderna Announces Positive Phase 3 Data for Combination Vaccine Against Influenza and COVID-19
Digital Journal· 1 day agomRNA-1083 met its primary endpoints, eliciting higher immune responses against influenza virus and SARS-CoV-2 than licensed flu and COVID ...
Roche Molecular Respiratory Virus Panel Receives FDA Emergency Use Authorization
GenomeWeb News· 23 hours agoThe PCR-based test detects SARS-CoV-2, influenza A/B, and respiratory syncytial virus from a nasal swab sample.
Moderna Announces Positive Phase 3 Data for Combination Vaccine Against Influenza and COVID-19
The Sacramento Bee· 1 day agomRNA-1083 met its primary endpoints, eliciting higher immune responses against influenza virus and SARS-CoV-2 than licensed flu and COVID ...
COVID-flu combo vaccine shows ‘positive’ results in phase 3 trials, Moderna says: A 'two-for' option
Fox News via Yahoo News· 14 hours agoModerna, which is developing a combination COVID-flu vaccine, announced on Monday that in phase 3...
Clinical trial shows 15-day Paxlovid regimen safe but adds no clear benefit for long COVID
Medical Xpress· 4 days agoIn a clinical trial conducted by Stanford Medicine investigators and their colleagues, a 15-day...
Virus that causes COVID-19 can remain in sperm for 110 days after infection
Medical Xpress· 7 days agoMore than four years after the start of the pandemic, we know SARS-CoV-2 is able to invade and...
Combined flu and Covid vaccine from Moderna shows positive trial results
PA Media: Science via Yahoo News· 21 hours ago“These findings are consistent across all tested influenza strains (H1N1, H3N2 and B/Victoria) and...
COVID-flu combo vaccine shows ‘positive’ results in phase 3 trials, Moderna says: A 'two-for' option
Fox News· 14 hours agoA combination COVID-influenza vaccine is apparently one step closer to hitting the market. Moderna,...